Sartorius Stedim Biotech SA (DIM) Stock Price & News

DIM:EPA

Sartorius Stedim Biotech SA

€215.00

-2.01%

(-4.40) 1D

Oct 16, 5:35:29 PM GMT+2 · EUR

All symbols

	Symbol	Price	Change	% Change

Next call in 4 days

Thu, Oct 22, 7:00 AM

Fiscal period

Q3 2026

- / €1.18

Revenue / Est. (EUR)

- / 758.87M

Fiscal Q3 2026 earnings call

Waiting for the earnings call

At a glance: upcoming earnings

Insights from the latest news and reports

Previous reportsAll values in EUR

Loading Previous Earnings...

All values in EUR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	705.70M	772.20M	761.50M	765.70M
Cost of goods sold	378.30M	455.30M	416.10M	406.90M
Cost of revenue	378.30M	455.30M	416.10M	406.90M
Research and development expenses	30.10M	31.70M	38.40M	35.30M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	157.60M	171.60M	163.40M	163.30M
Operating expense	192.70M	183.80M	196.10M	204.80M
Total operating expenses	571.00M	639.10M	612.20M	611.70M
Operating income	134.70M	133.10M	149.30M	154.00M
Other non operating income	-	-16.20M	-100.00K	-100.00K
EBT including unusual items	87.40M	77.70M	119.10M	126.60M
EBT excluding unusual items	87.40M	90.50M	119.10M	126.60M
Income tax expense	22.70M	30.50M	31.00M	32.90M
Effective tax rate	25.97%	39.25%	26.03%	25.99%
Other operating expenses	5.00M	-19.50M	-5.70M	6.20M
Net income	64.20M	47.30M	88.10M	93.00M
Net profit margin	9.10%	6.13%	11.57%	12.15%
Earnings per share	0.94	1.12	1.17	1.25
Interest and investment income	4.10M	7.60M	16.40M	6.90M
Interest expense	-51.40M	-24.50M	-46.50M	-34.20M
Net interest expenses	-47.30M	-16.90M	-30.10M	-27.30M
Depreciation and amortization charges	-	-	-	-
EBITDA	213.60M	138.90M	230.40M	233.40M
Gain or loss from assets sale	-	-	-	-

Finance